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Abstract:  Protein-DNA  conjugates  have  found  numerous  applications  in  the  field  of 
diagnostics  and  nanobiotechnology,  however,  their  intrinsic  susceptibility  to  DNA 
degradation by nucleases represents a major obstacle for many applications. We here report 
the selective covalent conjugation of the protein streptavidin (STV) with phosphorothioate 
oligonucleotides  (psDNA)  containing  a  terminal  alkylthiolgroup  as  the  chemically 
addressable  linking  unit,  using  a  heterobifunctional  NHS-/maleimide  crosslinker.  The 
psDNA-STV conjugates were synthesized in about 10% isolated yields. We demonstrate 
that the terminal alkylthiol group selectively reacts with the maleimide while the backbone 
sulfur atoms are not engaged in chemical conjugation. The novel psDNA-STV conjugates 
retain  their  binding  capabilities  for  both  biotinylated  macromolecules  and  the 
complementary nucleic acid. Moreover, the psDNA-STV conjugate retained its binding 
capacity  for  complementary  oligomers  even  after  a  nuclease  digestion  step,  which 
effectively  degrades  deoxyribonucleotide  oligomers  and  thus  the  binding  capability  of 
regular  DNA-STV  conjugates.  The  psDNA-STV  therefore  hold  particular  promise  for 
applications  e.g.  in  proteome  research  and  novel  biosensing  devices,  where  interfering 
endogenous nucleic acids need to be removed from analytes by nuclease digestion. 
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1. Introduction 
Almost 30 years ago, the enormous specificity of Watson-Crick base-pairing of synthetic DNA 
molecules had been recognized by Nadrian Seeman as a powerful means to rationally construct two- 
and  three-dimensional  assemblies  from  this  biopolymer  [1].  This  groundbreaking  research  has 
meanwhile led to the establishment of a vivid and fascinating field of research, often referred to as 
“DNA nanotechnology” [2], which nowadays can be considered as a mainstream direction in the area 
of  nanobiotechnology  [3].  One  important  topic  of  DNA  nanotechnology  and  nanobiotechnology 
concerns  the  synthesis  of  semisynthetic  conjugates  of  DNA  oligomers  and  proteins  [4].  Such 
conjugates  are  highly  versatile  building  blocks  because  they  allow  one  to  combine  the  unique 
properties of DNA with the almost unlimited variety of proteins, the latter of which were tailored by 
billions of years of natural evolution to perform highly specific functions, such as catalytic turnover, 
energy conversion, or translocation of other components. Consequently, a broad range of applications 
of  semisynthetic  DNA-protein  conjugates  have  meanwhile  been  demonstrated,  ranging  from 
nanofabrication  of  functional  devices  [4]  to  clinical  diagnostics  [5]  and  the  generation  of  protein 
microarrays  [6].  Covalent  DNA  conjugates  of  the  biotin-binding  protein  streptavidin  (STV)  are 
particularly noteworthy in the respect, because they combine the high-affinity binding of STV for four 
molecules of D-biotin with an additional binding site for the complementary nucleic acid. Since their 
initial description [7], these conjugates have therefore been used as versatile adaptors to readily label 
biotinylated  proteins  with  an  oligonucleotide  moiety  to  realize  numerous  in  vitro  applications  in 
sensing and biomedical diagnostics [4,6]. However, the intrinsic susceptibility of the tethered DNA 
oligomers to degradation by nucleases, has so far limited the employment of DNA-STV conjugates for 
in  vivo  experiments,  for  instance,  in  the  so-called  BioPlex  technology,  in  which  cell-penetrating 
ligands are assembled by means of DNA hybridization to tether combinatorial mixtures of ligands to a 
plasmid to facilitate cell uptake and gene delivery [8,9].  
To  overcome  the  limited  stability  in  complex  media,  several  DNA  analogues  have  been 
synthesized, which display an increased nuclease stability, such as phosphorothioate DNA (psDNA) 
[10], PNA, LNA, or morpholino DNA [11]. While peptide conjugates of nucleic acids are accessible 
by  a  variety  of  solid  phase-based  synthetic  approaches  [12],  to  the  best  of  our  knowledge,  no 
conjugates  of  psDNA  comprising  whole  proteins  have  been  described  yet.  We  here  report  on  the 
synthesis  and  characterization  of  well-defined,  covalent  conjugates  of  phosphorothioate  DNA 
oligomers and streptavidin (psDNA-STV) (Figure 1).  
Notably, although previous work suggested “considerable thiol character” of the backbone sulfur 
atoms of the psDNA oligomers [5,13,14], we here demonstrate that psDNA oligomers do not react 
with  the  maleimide-based  crosslinker  sSMCC  [4-(N-maleimidomethyl)cyclohexane-1-carboxylic-3-
sulfo-n-hydroxysuccinimide ester] in the absence of a terminal alkylthiol group, thus giving rise to 
selective  coupling.  We  demonstrate  that  the  novel  psDNA-STV  conjugates  retain  their  binding 
capabilities for both biotinylated macromolecules and the complementary nucleic acid. Owing to the 
stability  of  the  tethered  phosphorothioate  oligonucleotide  against  nucleases,  the  psDNA-STV 
conjugates retained their full binding capacity  for complementary oligomers even  after  a nuclease 
digestion step. In contrast, the nuclease digestion efficiently decreased the binding capacity of regular 
DNA-STV conjugates. We thus anticipate that the psDNA-STV conjugates will be particularly suited Molecules 2011, 16                                       
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for  applications  within  living  cells,  such  as  gene  delivery  [8],  or  in  proteome  research,  where 
interfering endogenous nucleic acids have to be removed from analyte samples by rigorous nuclease 
digestion  [15,16].  Moreover,  the  robust  psDNA-STV  conjugates  should  find  applications  in  the 
development of novel biosensing devices. 
Figure  1.  Reaction  of  sSMCC-activated  streptavidin  with  5’-C6-alkylthiol-
phosphorothioate DNA. Note that the terminal alkylthiol group selectively reacts with the 
maleimide while the backbone sulfur atoms do not contribute to conjugation. 
 
2. Results and Discussion 
To synthesize the target psDNA-STV conjugates, we adopted the procedure, previously developed 
for the analogous regular DNA-STV conjugates [7]. In brief, native STV is initially modified with 
maleimide  groups,  using  an  excess  of  the  heterobispecific  crosslinker  sSMCC.  In  parallel,  any 
disulfide  contaminants  within  the  5’-alkylthiol-modified  phosphothioate  DNA,  either  psF5  (1)  or 
psF10 (2) oligomers (for sequences, see Table 1) were reduced to enable efficient coupling of the 
maleimide  activated  STV.  While  we  had  previously  optimized  this  disulfide  reduction  step  with 
dithiothreitol  (DDT)  [17],  we  observed  that  the  psDNA  revealed  higher  coupling  efficiency  when 
tris(2-carboxyethyl)phosphine (TCEP) was used as reducing agent. Since TCEP does not interfere with 
the thiol-maleimide reaction, this change in protocol brought also with it the advantage that no time-
consuming  separations  of  the  reducing  agents  are  necessary.  We  first  investigated  whether  the 
backbone phosphates were also reactive towards sSMCC. To this end, we reacted the psF5 with an 
excess of sSMCC and butylamine. After purification the reaction products were analyzed by MALDI-
TOF.  It  is  shown  in  Figure  S1  that  products  revealed  an  increase  in  mass  of  310  m/z.  Since  the 
observed m/z value is in good agreement with the expected mass increase of 293, and the difference of 
+17 mass units might reflect the presence of an NH4
+-adduct, we concluded that the phosphorothioates 
exclusively react with the sSMCC at their 5’-alkythiol group. This hypothesis was further confirmed 
by  additional  controls  with  alkylamino-modified  psF5,  which  revealed  no  reactivity  with  
SMCC-activated STV (see Figure S2).  Molecules 2011, 16                                       
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In order to covalently couple psF5 or psF10 with STV, the psDNA- and STV-containing solutions 
were mixed and incubated for 90 minutes. The crude reaction mixture was purified via FPLC on a 
MonoQ anion exchange column, to separate the psDNA-STV conjugate from remaining unreacted 
streptavidin (Figure 2).  
Figure  2.  Anion-exchange  FPLC  chromatogram  of  the  purification  of  psF5-STV. 
Streptavidin without psDNA (a) is separated from the psDNA-STV conjugate (b) and free 
psDNA (c). On the right axis the amount of NaCl in the mobile phase is depicted. Note that 
the  relative  absorbances,  measured  at  280  nm  (red  line)  and  260  nm  (black  line)  are 
indicative for either the STV or the psDNA-STV conjugate. 
 
Using a linear 0-3 M NaCl gradient, the desired psDNA-STV conjugate [peak (b) in Figure 2] could 
be separated from unreacted STV [peak (a) in Figure 2] and free DNA [peak (c) in Figure 2]. Similar 
chromatograms were obtained for the reaction of psF10 with STV (Figure S3). Since the ratio of 
A260/A280 absorbance is indicative for the coupling stoichiometry, absorbance measurements at 260 
and 280 nm and comparison with a calibration curve (Figure S4) indicated that the product in peak (b) 
represented the psDNA-STV conjugate with a mainly 1:1 stoichiometric ratio of psDNA and STV. The 
conjugate containing fractions were pooled and concentrated and the isolated yields were determined 
to be approximately 10%, calculated from the initial amount psDNA. These yields are in the similar 
range as observed for regular DNA-STV conjugates obtained from deoxyribonucleotides [7,9,17,18] 
Moreover,  a  survey  of  the  literature  clearly  indicates  that  isolated  yields  of  10–20%  are  common 
average for the synthesis of DNA-protein conjugates, thereby opening the door to a vast variety of 
practical applications in biosensing and nanosciences [4].  
The purity and hybridization capabilities of the resulting psDNA streptavidin conjugates, containing 
either the F5 or F10 psDNA, were initially analyzed by gel-shift experiments using a non-denaturating 
polyacrylamid gel (Figure 3).  
To this end, psF5-STV or/and psF10-STV were either applied to the gel alone or else mixed with 
two  molar  equivalents  of  a  103-mer  oligonucleotide  containing  sequence  stretches,  which  are 
complementary  to  the  F5  and  F10  psDNA  linked  to  STV.  The  gel  indicated  that  psDNA-STV 
conjugates alone (lanes 3, 5, 7) are only weakly stained by SybrGold, a phenomenon also observed for 
regular  ssDNA-STV  conjugates  [19].  However,  strongly  stained  bands  were  clearly  observable  in Molecules 2011, 16                                       
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samples containing the 103-mer oligonucleotide (lanes 1, 2, 4, 6), where bands with a slightly higher 
electrophoretic  mobility  as  the  faint  bands  of  the  pure  psDNA-STV  conjugates  suggested  that 
hybridization of the 103-mer strand with the psDNA-STV conjugates readily occurred. When both 
psF5- and psF10-STV conjugate were present, one additional strong band with decreased mobility was 
visible (lane 6), indicating the formation of the trimolecular complex, comprising the two conjugates 
and the 103-mer carrier strand. Although two molar equivalents of the 103-mer carrier were present, 
the trimolecular complex formed with approximately 40% yield, according to greyscale analysis. This 
suggests that the hybridization of the psDNA-STV conjugates is not significantly affected by steric 
hindrance  due  to  binding  of  both  conjugates  on  the  same  103-mer  carrier.  Concluding,  the 
electrophoresis results therefore confirmed that (i) the psDNA-STV conjugates were synthesized as 
pure compounds and (ii) that they were capable of specific hybridization with complementary nucleic 
acids.  To  further  investigate  the  hybridization  properties  of  the  psDNA-STV  conjugates,  we  used 
DNA-directed  immobilization  (DDI)  in  microplates  containing  complementary  capture 
oligonucleotides, similar as depicted in Figure 4, however, without any nuclease digestion step. 
Figure  3.  Non-denaturating  8%  polyacrylamide  gel  electrophoresis  (ndPAGE)  with 
subsequent SybrGold staining of samples containing psDNA-STV conjugates (5 pmol) and 
a  complementary  103-mer  oligonucleotide  (10  pmol).  Lane  M:  50bp  MassRuler  from 
Fermentas, lane 1: 103mer alone, lane 2: 103mer and psF5-STV, lane 3: psF5-STV alone, 
lane 4: 103mer and psF10-STV, lane 5: psF10-STV alone, lane 6: 103mer, psF5-STV, 
psF10-STV, lane 7: psF5-STV and psF10-STV. The faint band co-migrating with 200 bp 
marker in lane 1 indicates the presence of low amounts of homodimers of the 103mer 
oligonucleotide. These homodimers can also bind the STV conjugates leading to the faint 
bands in lane 2 and 4 which have lower mobility than the 1:1 assembly of conjugate and 
103mer. Note that both psDNA-STV do bind to the 103-mer simultaneously (lane 6). 
 
 
To this end, 5’-biotinylated oligomers cF5 and cF10, which are complementary to the psF5- and 
psF10-STV conjugate, respectively, were immobilized in wells of a streptavidin-coated microplate. 
The  psF5-  and  psF10-STV  conjugates  were  coupled  in  homogeneous  solution  with  one  molar 
equivalent of biotinylated alkaline phosphatase (bAP), and the resulting psDNA-STV-AP conjugates 
were  allowed  to  bind  to  the  microplate-immobilized  capture  oligonucleotides.  Subsequent  to 
hybridization and removal of excess materials, hybridization efficiency was monitored by AP activity, 
using  the  fluorogenic  substrate  AttoPhos.  As  shown  in  Figure  5,  high  AP  activity  was  detected 
exclusively  in  wells  which  contained  the  complementary  capture  strand,  and  no  significant  cross-
hybridization  was  observed.  Also,  non-specific  adsorption  was  negligible  in  controls  where  only Molecules 2011, 16                                       
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biotinylated alkaline phosphatase was present in the wells. These results demonstrate that the psDNA-
STV  conjugates  possess  the  similar  specificity  in  DNA  recognition  as  the  analogous  conjugates, 
comprising regular DNA oligonucleotides. 
Figure 4. Schematic illustration of the DDI experiments. Biotinylated alkaline phosphatase 
(bAP) is bound to the STV conjugates in a first step and detected after the DNA-directed 
immobilization. In case (a) the standard DNA will be digested and the complex is not 
detectable,  whereas  the  phosphorothioate  DNA  used  in  case  (b)  withstands  nuclease 
treatment, thus resulting in detectable bAP activity. 
 
To  experimentally  demonstrate  the  increased  stability  of  the  psDNA-STV  conjugates  against 
nucleases, we used exonuclease I from E. coli. This nuclease is known to efficiently digest single-
stranded DNA from the 3’- to the 5’-end. Since linkage of the DNA (psF5 or F5) to the STV occurred 
via the 5’-thiolgroup, the 3’-end of the oligomers should be susceptible to degradation by Exonuclease 
I  (Figure  4).  In  contrast,  the  microplate-bound  capture  oligomers  were  immobilized  via  their  
3’-biotinylated ends, which should prevent them from being digested by this nuclease. To investigate 
nuclease stability, the psF5-STV conjugate as well as a F5-STV conjugate, comprised of standard 
DNA-bases, were coupled in homogeneous solution with one molar equivalent of biotinylated alkaline 
phosphatase (bAP). Subsequently half of the sample was treated with exonuclease I to digest the DNA 
present in the STV conjugate, the other half was left unchanged. The resulting AP-DNA-STV samples 
were hybridized to microplate-immobilized cF5-capture-oligonucleotides. After removal of unbound 
materials,  the  hybridization  efficiency  was  monitored  using  the  fluorogenic  substrate  Attophos  as Molecules 2011, 16                                       
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described before. The resulting data is presented in Figure 6. The phosphatase activity detected for the 
F5-STV conjugate after digestion with exonuclease I was decreased by more than 90% whereas the 
activity in case of psF5-STV conjugate was virtually unchanged. This clearly shows that the psDNA 
conjugates exhibit the expected nuclease stability. 
Figure 5. Phosphatase activity detected by AttoPhos assay in a multiwellplate DDI assay. 
Complementary capture oligonucleotides cF5 or cF10 were immobilized in the wells (black 
and white bars, respectively), and the indicated samples, containing either psF5- or psF10-
STV-bAP conjugates or bAP alone, were allowed to hybridize. Activity of immobilized 
phosphatase was detected using the AP substrate AttoPhos. Note that signals only occur in 
wells containing complementary capture oligomers. 
 
Figure  6.  Phosphatase  activity  detected  in  the  DDI  assay  depicted  in  Figure  4  after 
nuclease  digestion  by  exonuclease  I  from  E.  coli.  Capture  oligonucleotides  cF5  were 
immobilized,  and  the  wells  were  incubated  with  samples  containing  either  psF5-  or  
F5-STV-bAP conjugates, which were treated (black bars) or not treated (white bars) with 
exonuclease I digestion. Note that the psF5-STV-bAP retained its full binding capability 
while the F5-STV-bAP was efficiently degraded by the nuclease. 
 Molecules 2011, 16                                       
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3. Experimental  
3.1. Chemicals and Materials  
KH2PO4, K2HPO4, TRIS, HCl, NaCl, borate and EDTA were from VWR. The crosslinker sSMCC 
and tris(2-carboxyethyl)phosphine (TCEP) were purchased from Pierce. DMF and milk powder were 
supplied  by  Sigma.  β-Mercaptoethanol  and  Tween  20  were  from  Roth.  Acrylamide  solution  was 
purchased at Merck, DNA ladder and loading dye at Fermentas. DTT was from Applichem, Biotin 
from  Fluka  and  SybrGold  from  Invitrogen.  Exonuclease  I  was  supplied  by  NEB  and  
biotinylated  alkaline  phosphatase  by  Abcam.  5’-C6-alkylthiol-oligonucleotides,  5’-C6-alkylamino-
phosphorothioate  and  5’-C6-alkylthiol-phosphorothioate  olgonucleotides  were  synthesized  by  TIB 
MOLBIOL, the 3’-biotinylated as well as the unmodified oligonucleotides by Sigma. The AttoPhos 
detection kit was from Roche, the NAP5 and NAP10-columns from GE Healthcare and the Vivaspin 
concentrators from Satorius. 
3.2. DNA Sequences 
Table 1. Oligonucleotide sequences and their corresponding abbreviation in the text. 
Number  Name  Sequence 
(1)  psF5  5'-cggtcataaagcgataag -3', whole backbone is phosphorothioate 
(2)  psF10  5'-gaatacaaaggctacacg -3', whole backbone is phosphorothioate 
(3)  103mer  5'-tgtacgtcacaactacttatcgctttatgaccggacccgtgtagcctttgtattcgtccctt 
cacgattgccactttccacgtacttccttaaacgacgcagg-3' 
(4)  cF5  5'-cttatcgctttatgaccggacc -3' 
(5)  cF10  5'-cgtgtagcctttgtattcgtcc -3' 
(6)  F5  5'-ggtccggtcataaagcgataag-3' 
(7)  cF9  5'-cttcacgattgccactttccac -3' 
3.3. Synthesis of Covalent Phosphorothioate DNA-sSMCC Conjugates 
In an initial test reaction, phosphorothioate psF5-oligonucleotide (1) (20 µL) containing a 5’-C6-
alkylthiol group (100 µM in 1 mM TRIS-HCl, 0.1 mM EDTA pH 8.0) was mixed with sSMCC (2 mg 
dissolved in 60 µL DMF) and incubated for 90 minutes at room temperature in the dark. Subsequently 
the oligonucleotide-bound sSMCC was reacted with 500 molar excess of butylamine. The reaction 
product was separated from remaining unreacted sSMCC and butylamine by gel filtration using NAP5 
columns. The resulting solution was concentrated to dryness by vacuum concentration, resuspended in 
H2O  (20  µL)  and  1  µL  of  the  solution  was  analyzed  by  MALDI-TOF  on  a  Voyager-DETM  Pro 
Biospectrometry Workstation (Perseptive Biosystems). The spectra are shown in the Supplementary 
Materials (Figure S1).  
3.4. Synthesis, Purification and Characterization of Covalent Phosphorothioate DNA-Streptavidin 
(psDNA-STV) Conjugates 
Phosphorothioate  oligonucleotide  [100  µL,  either  psF5  (1)  or  psF10  (2)]  containing  a  5’-C6-
alkylthiol group (100 µM in 1 mM TRIS-HCl, 0.1 mM EDTA pH 8.0) were activated by the addition Molecules 2011, 16                                       
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of tris(2-carboxyethyl)phosphine (TCEP, 10 µL in 10 mM in 1 mM TRIS-HCl, 0.1 mM EDTA pH 8.0) 
for 3 hours at room temperature. Streptavidin (200 µL, 100 µM in 50 mM KPi, 150 mM NaCl pH 7.4) 
was mixed with sSMCC (2 mg dissolved in 60 µL DMF)  and incubated for 90 minutes at room 
temperature in the dark. Streptavidin was separated from remaining unreacted sSMCC by two gel 
filtration steps using NAP5 and NAP10 columns. The eluate was immediately  combined with the 
oligonucleotide  and  incubated  for  90  minutes  in  the  dark.  The  reaction  was  then  stopped  by  the 
addition of 1 M β-mercaptoethanol and the mixture was purified by anion exchange chromatography 
on  an  automated  FPLC  system  (Äkta  Purifier,  GE  Healthcare),  using  a  MonoQ  5/5  column 
equilibrated with 20 mM TRIS/HCl pH 7.5, and a gradient of NaCl ranging from 0 to 3 M (Figure 2). 
The conjugate containing fractions were pooled and concentrated using Vivaspin concentrators with a 
molecular weight cut-off of 10.000 Da. Non-denaturing gel-electrophoresis on a 8% polyacrylamide 
gel  (ndPAGE)  was  used  to  analyze  the  purity  of  the  conjugates  and  their  hybridization  with 
complementary DNA oligomers (Figure 3). Electrophoresis buffer was 89 mM Tris, 89 mM Borate,  
2 mM EDTA, pH 8.3. To analyze the hybridization properties of the psDNA-STV, 5 pmol of each 
conjugate was premixed with 10 pmol of a 103mer DNA oligonucleotide (3) containing an 18 base-
pair stretch complementary to the phosphorothioate DNA in a total volume of 10 µL in water. The 
mixture was incubated for 5 minutes at room temperature, mixed with loading dye (2 µL) and applied 
on the gel. Electrophoresis was carried out for 20 minutes at 20 V/cm and the gel was subsequently 
stained with SybrGold. 
3.5. Analysis of the Conjugate Integrity by DNA-Directed Immobilization (DDI) 
DDI was carried out as described before, using streptavidin-coated microtiterplates (17). In brief, 
the  plates  were  washed  with  TETBS  buffer  (20  mM  Tris,  5  mM  EDTA,  150  NaCl,  0.05%  (v/v) 
Tween20), a 240 nM solution of the 5’-biotinylated capture DNA oligonucleotides [cF5 (4) and cF10 
(5), 50 µL] were immobilized, and excess biotin-binding sites were blocked with TETBS containing 
0.8 mM D-biotin and 0.45% (w/v) milk powder. Biotinylated alkaline phosphatase (AP, 10 pmol) was 
mixed  with  either  10  pmol  psF5-STV  (1),  10 pmol  psF10-STV  (2)  or  PBS-buffer  only  in  a  total 
volume of 20 µL and incubated for 10 minutes at RT. The blocking buffer was removed from the 
multiwellplate and after further washing the samples were allowed to hybridize with the surface-bound 
DNA  for  90  minutes.  Unbound  sample  was  removed  by  washing  with  TETBS  twice.  AttoPhos 
detection solution was prepared as described in the suppliers manual and the immobilized complex 
was  then  detected  through  the  conversion  of  the  phosphatase  substrate  AttoPhos  by  the  alkaline 
phosphatase yielding fluorescent signals, which were recorded using a Synergy multiwellplate reader 
(BIO-TEK). 
3.6. Nuclease Digestion Assay 
For  each  sample  10  pmol  of  either  the  psDNA-STV  [psF5-STV  (2)]  or  the  analogous  regular 
conjugate [F5-STV, (6)], containing a deoxyribonucleic acid moiety, were mixed with biotinylated 
alkaline phosphatase (AP) in a 1:1 ratio and incubated for 10 minutes at room temperature in 20 µL 
reaction  volume.  Subsequently  each  sample  was  split  into  two  aliquots,  one  of  which  was  then 
subjected  to  a  nuclease  digestion.  To  this  end,  10  µL  of  the  sample  were  mixed  with  2.5  µL  Molecules 2011, 16                                       
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10×  exonuclease  I  buffer  and  1  µL  exonuclease  I  (20Units/µL)  in  a  total  volume  of  25  µL  and 
incubated for 30 minutes at 37 °C. The other 10 µL aliquot of the sample were treated in the same way, 
but  omitting  the  exonuclease  I.  Subsequently,  the  samples  were  diluted  with  TETBS  containing  
0.8 mM D-Biotin and 0.45% (w/v) milk powder to a total volume of 100 µL, thus leading to final 
concentrations  of  the  Oligonucleotide-STV-AP  conjugates  of  100  nM.  Fifty  µL  of  the  resulting 
solution were then allowed to bind to microplate immobilized capture oligomers [either cF5 (4) or cF9 
(7)]  prepared  as  described  above.  The  hybridization  event  was  analyzed  by  addition  of  AttoPhos 
substrate prepared and carried out as described above. 
4. Conclusions 
In this work, we demonstrate that psDNA-STV conjugates can be readily prepared by maleimide-
based  coupling  chemistry.  As  shown  by  ndPAGE  and  DDI,  the  resulting  conjugates  display 
undisturbed hybridization properties. In contrast to standard oligonucleotide DNA-STV conjugates, 
which are rapidly degraded by DNA nuclease, the psDNA-STV conjugates remained nearly untouched 
upon treatment with exonuclease I. We anticipate that the synthetic approach described here should be 
equally applicable to other proteins, thereby enabling access to a new class of sturdy bioconjugates for 
intracellular or in vivo applications in cell biology, bioanalytics or nanobioscience.  
Supplementary Materials 
Supplementary materials can be accessed at http://www.mdpi.com/1420-3049/16/8/6916/s1. 
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